시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 색소침착증 치료 시장 보고서(2025년)
Hyperpigmentation Disorder Treatment Global Market Report 2025
상품코드 : 1824284
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 색소침착증 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 8.7%로 확대되어 85억 6,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 비침습적 치료에 대한 주목, 스킨케어 의식의 향상, 원격의료와 가상진찰, 규제지원과 승인, 맞춤 치료 옵션 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향은 혁신적인 국소 제형, 레이저 기술의 진보, 병용 요법의 중시, 개인화 치료 접근법, 천연 제품에 대한 수요 증가 등이 있습니다.

향후 5년간의 성장률 8.7%라는 예측은 지난 예측으로부터 0.2% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세장벽은 한국이나 이탈리아에서 조달되는 트라넥삼산 외용제나 레이저 치료기기의 비용을 상승시킴으로써 미국을 괴롭히고, 미용 및 의료 피부과 치료에 대한 액세스를 저하시켜, 자기 부담액을 상승시킬 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

색소 침착 장애의 유병률 증가가 예상되기 때문에 색소침착증 치료 시장의 성장이 촉진될 것으로 예측됩니다. 색소 침착 장애는 피부, 모발 및 눈의 홍채의 색조에 영향을 미치는 다양한 상태를 포함하며, 전형적으로 멜라닌 세포에 의해 생성되는 염료인 멜라닌 문제로 인한 것입니다. 색소침착증의 치료법은 근본적인 원인이나 중증도에 따라 다르며, 경증의 경우에는 아젤라산, 시스테아민 크림, 비타민 C, 하이드로퀴논 등 미백작용으로 알려진 성분을 포함한 시판 외용 크림으로 대처하는 경우가 많습니다. 예를 들어, 2023년 3월 미국 질병관리센터(CDC) 보고서는 미국에서 칸디다속 진균 사례 수가 2019년 476명에서 2021년 1,471명으로 증가했다고 강조했습니다. 또한 국립건선재단은 2022년 12월에 건선은 세계에서 1억 2,500만 명이 앓고 있으며, 이는 전체 인구의 2-3%에 상당한다고 보고하고 있습니다. 색소 침착 장애의 유병률 증가는 색소침착증 치료 시장의 성장을 가속할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Hyperpigmentation disorder treatment involves various methods aimed at reducing the appearance of dark spots or patches on the skin caused by excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid are commonly used to lighten the skin.

Treatment types in the hyperpigmentation disorder treatment market include cosmeceuticals, laser therapy, chemical peels, microdermabrasion, phototherapy, and other treatments. Cosmeceuticals are cosmetics with active ingredients that may have therapeutic effects on the skin. They are utilized to treat various conditions, including melasma, post-inflammatory hyperpigmentation, solar lentigines, and other indications. These treatments are administered by various end-users, including hospitals, esthetic clinics, dermatology centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hyperpigmentation disorder treatment market research report is one of a series of new reports from The Business Research Company that provides hyperpigmentation disorder treatment optical components market statistics, including hyperpigmentation disorder treatment optical components industry global market size, regional shares, competitors with a hyperpigmentation disorder treatment optical components market share, detailed hyperpigmentation disorder treatment optical components market segments, market trends and opportunities, and any further data you may need to thrive in the hyperpigmentation disorder treatment optical components industry. This hyperpigmentation disorder treatment optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.73 billion in 2024 to $6.12 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to clinical trials and research, advances in chemical peels, cultural shift towards skincare, emphasis on non-invasive options, demand for natural products.

The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $8.56 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to focus on non-invasive treatments, enhanced skincare awareness, telemedicine and virtual consultations, regulatory support and approvals, personalized treatment options. Major trends in the forecast period include innovative topical formulations, advancements in laser technologies, focus on combination therapies, personalized treatment approaches, rising demand for natural products.

The forecast of 8.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of topical tranexamic acid and laser therapy devices sourced from South Korea and Italy, thereby reducing access to cosmetic and medical dermatology treatments and elevating out-of-pocket costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected increase in the prevalence of pigmentation disorders is anticipated to fuel the growth of the hyperpigmentation disorders treatment market. Pigmentation disorders encompass various conditions affecting the coloration of the skin, hair, and eye iris, typically resulting from issues with melanin, the pigment produced by melanocytes. Treatment options for hyperpigmentation disorders vary based on the underlying cause and severity, with mild cases often managed through over-the-counter topical creams containing ingredients such as azelaic acid, cysteamine cream, vitamin C, and hydroquinone, known for their skin-lightening properties. For example, a report from the Centers for Disease Control (CDC) in March 2023 highlighted an increase in Candida auris cases in the US from 476 in 2019 to 1,471 in 2021. Additionally, the National Psoriasis Foundation reported in December 2022 that psoriasis affects 125 million people globally, representing 2 to 3 percent of the overall population. The rise in pigmentation disorders' prevalence is expected to drive the growth of the hyperpigmentation disorders treatment market.

The growth of the hyperpigmentation disorder treatment market is further propelled by increasing cosmetic concerns. Cosmetic concerns refer to worries or considerations related to one's physical appearance, beauty, or aesthetics. The rising focus on cosmetic concerns encourages individuals to seek hyperpigmentation disorder treatments, fostering innovation in the cosmetic and dermatological industries and enhancing the overall patient experience. Reports from the International Society of Aesthetic Plastic Surgery (ISAPS) in September 2023 revealed that plastic surgeons are expected to perform over 14.9 million surgical and 18.8 million non-surgical operations in 2022, reflecting an overall increase of 11.2%. The heightened emphasis on cosmetic concerns is a significant driver behind the growth of the hyperpigmentation disorder treatment market.

Major companies in the hyperpigmentation disorders treatment market are concentrating on developing glycolic acid solutions to enhance their market position and secure a competitive edge. Glycolic acid solutions are skincare formulations that contain glycolic acid, an alpha hydroxy acid (AHA) recognized for its exfoliating benefits, which help to improve skin texture, brightness, and overall appearance by encouraging cell turnover. For example, in February 2024, L'Oreal SA, a personal care company based in France, introduced the Glycolic Bright Dark Circle Eye Serum, designed to address dark circles and dullness around the eyes. This innovative serum utilizes glycolic acid for its exfoliating effects, promoting brighter skin and improved texture. The formulation likely also incorporates hydrating ingredients to nourish the sensitive eye area.

Major players in the hyperpigmentation disorder treatment market are strategically launching innovative products to meet the growing demand for effective and safe hyperpigmentation treatment. A noteworthy example is the Cyspera Intensive System, unveiled by Cyspera (Scientis SA), a Switzerland-based dermatology company. This revolutionary three-step hyperpigmentation treatment is meticulously designed to target persistent brown patches and dark spots. The system features a proprietary Cysteamine Isobionic-Amide Complex, a patented melanosomal transfer inhibitor within the vitamin B3 family. This complex collaborates synergistically with cysteamine to deliver three powerful effects. In essence, the Cyspera Intensive System emerges as a promising new option for hyperpigmentation treatment, ensuring safety and efficacy for all skin types without harsh chemicals.

In July 2023, Reveal Lasers LLC, a US-based manufacturer of aesthetic lasers and RF devices, merged with NEOconcepts LLC. This merger allows Reveal Lasers to acquire the AgeJET Advanced Plasma Skin Therapy Device, facilitating its entry into a new treatment area and strengthening AgeJET's presence in the US market. NEOconcepts LLC specializes in providing aesthetic treatment products and devices.

Major companies operating in the hyperpigmentation disorder treatment market include Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Bayer AG, Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, Episciences Inc., La Roche-Posay, L'Oreal S.A., Pierre Fabre Laboratories, Alvogen Inc., Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Incyte Corporation, Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries, SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estee Lauder Companies Inc.

North America was the largest region in the hyperpigmentation disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hyperpigmentation disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hyperpigmentation disorder treatment market consists of revenues earned by entities by providing hyperpigmentation disorder treatment services such as microdermabrasion and tropical treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperpigmentation disorder treatment market also includes sales of serums, creams, gels or lotions formulated for the treatment of hyperpigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperpigmentation Disorder Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperpigmentation disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hyperpigmentation disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hyperpigmentation disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Hyperpigmentation Disorder Treatment Market Characteristics

3. Hyperpigmentation Disorder Treatment Market Trends And Strategies

4. Hyperpigmentation Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hyperpigmentation Disorder Treatment Growth Analysis And Strategic Analysis Framework

6. Hyperpigmentation Disorder Treatment Market Segmentation

7. Hyperpigmentation Disorder Treatment Market Regional And Country Analysis

8. Asia-Pacific Hyperpigmentation Disorder Treatment Market

9. China Hyperpigmentation Disorder Treatment Market

10. India Hyperpigmentation Disorder Treatment Market

11. Japan Hyperpigmentation Disorder Treatment Market

12. Australia Hyperpigmentation Disorder Treatment Market

13. Indonesia Hyperpigmentation Disorder Treatment Market

14. South Korea Hyperpigmentation Disorder Treatment Market

15. Western Europe Hyperpigmentation Disorder Treatment Market

16. UK Hyperpigmentation Disorder Treatment Market

17. Germany Hyperpigmentation Disorder Treatment Market

18. France Hyperpigmentation Disorder Treatment Market

19. Italy Hyperpigmentation Disorder Treatment Market

20. Spain Hyperpigmentation Disorder Treatment Market

21. Eastern Europe Hyperpigmentation Disorder Treatment Market

22. Russia Hyperpigmentation Disorder Treatment Market

23. North America Hyperpigmentation Disorder Treatment Market

24. USA Hyperpigmentation Disorder Treatment Market

25. Canada Hyperpigmentation Disorder Treatment Market

26. South America Hyperpigmentation Disorder Treatment Market

27. Brazil Hyperpigmentation Disorder Treatment Market

28. Middle East Hyperpigmentation Disorder Treatment Market

29. Africa Hyperpigmentation Disorder Treatment Market

30. Hyperpigmentation Disorder Treatment Market Competitive Landscape And Company Profiles

31. Hyperpigmentation Disorder Treatment Market Other Major And Innovative Companies

32. Global Hyperpigmentation Disorder Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hyperpigmentation Disorder Treatment Market

34. Recent Developments In The Hyperpigmentation Disorder Treatment Market

35. Hyperpigmentation Disorder Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기